| |
| |
|
| Insider
Information: |
Gryska David W |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
174,851 |
|
|
Indirect Shares
|
750 |
|
|
| Direct
Value |
$990,650 |
|
|
|
Indirect Value
|
$81,180 |
|
|
| Total
Shares |
175,601 |
|
|
| Total
Value |
$1,071,830 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 15.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2006-02-14 |
0 |
Premium* |
|
|
Celgene Corp |
CELG |
Chief Financial Officer |
2010-05-04 |
864 |
2010-05-04 |
750 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2020-12-30 |
1,387 |
2014-03-06 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Executive Vice Preside... |
2018-07-16 |
10,235 |
2015-01-08 |
0 |
Premium* |
|
|
Aerie Pharmaceuticals Inc |
AERI |
Director |
2022-11-21 |
0 |
2022-11-21 |
0 |
Premium* |
|
|
Mind Medicine |
MNMD |
Director |
2023-06-21 |
13,851 |
2023-06-21 |
0 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
Director |
2023-07-31 |
148,514 |
2023-07-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
104 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
Director |
– • – |
2013-07-16 |
5 |
GD |
$0.00 |
$0 |
D/D |
250 |
21,750 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2018-07-05 |
4 |
D |
$68.28 |
$19,118 |
D/D |
(280) |
10,690 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2018-07-16 |
4 |
D |
$70.19 |
$31,936 |
D/D |
(455) |
10,235 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2010-12-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
500 |
25,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2012-08-06 |
5 |
GD |
$0.00 |
$0 |
D/D |
500 |
11,000 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-06-30 |
4 |
OE |
$73.21 |
$43,853 |
D/D |
599 |
19,614 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-06-30 |
4 |
AS |
$129.74 |
$77,714 |
D/D |
(599) |
19,015 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-09-13 |
4 |
D |
$123.15 |
$87,683 |
D/D |
(712) |
21,820 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2018-02-20 |
4 |
D |
$86.03 |
$92,052 |
D/D |
(1,070) |
12,922 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,335 |
49,348 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-04-28 |
4 |
OE |
$67.06 |
$93,146 |
D/D |
1,389 |
20,404 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-04-28 |
4 |
AS |
$124.26 |
$172,597 |
D/D |
(1,389) |
19,015 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,402 |
46,250 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,503 |
47,753 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2015-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,700 |
1,700 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
1,750 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2020-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
3,500 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
5,250 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2018-02-21 |
4 |
AS |
$85.56 |
$167,013 |
D/D |
(1,952) |
10,970 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2022-11-21 |
4 |
D |
$15.25 |
$30,439 |
I/I |
(1,996) |
0 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,044 |
51,047 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2006-05-09 |
4 |
A |
$4.59 |
$11,484 |
D/D |
2,500 |
7,500 |
|
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2016-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,610 |
13,460 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
48,013 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,022 |
10,850 |
0 |
- |
|
104 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
